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tervention for recoarctation) or failures at immediate (0-1 mo.). intermediate
(1-72 mos.) and long-term (> 72 mos.) follow-up (FU) intervals. Comparisons
between categories of arch measures were performed for each FU interval.
Results: At immediate FU, the following differences between outcome cate-
gories were observed:
Echo Measurement Success (n = 83) Failure In = 22) Pvalue
Aortic Annulus (cm/BSAO.5) 1.48 ± 020 135 ± 023 <0.025
Distal Aortic Arch (cm/BSAO.5) 115±020 095 ± 0.17 <00001
Isthmus Icm/BSAO.5) 1.04 ± 0.17 0.79 ± 0.10 <00001
Isthmus z-score -1.14 ± 0.98 -2.61 ± 0.53 <00001
Isthmic Volume (ml/BSA1.5) 0.63 ± 0.35 0.30 ± 0.20 <0.0001
Coarctation Site (cm/BSAO.5) 054 ± 014 0.49 ± 0.10 NS
Isthmus/Descending Aorta 0.91 ± 0.18 0.68±014 <0.0001
At intermediate FU, the above variables achieved similar statistical signif-
icance in describing differences between success (n = 54) and failure (n =
21). Logistic regression ana~sis using isthmus z-score yielded a prediction
model P (Fail) = (1 +e-6.22- .39Z)-1 In the Immediate group. An Isthmus z-
score ~ -2.16 predicted failure (91 % sensitivity, 85% specificity). In the in-
termediate FU group, stepwise logistic regression with aortic annulus, isth-
mus z-score and coarctation sitelisthmus ratio yielded a model predicting
failure with 91 % sensitivity and 81 % specificity. Though less sensitive (39%),
echocardiographic presence of patent ductus arteriosus was a highly spe-
cific (93%) predictor of failure at immediate and intermediate FU, with posi-
tive predictive value of 81 %. A single patient failed during the long-term FU
interval. Conclusion: Quantitative echocardiographic analysis of aortic arch
morphometry predicts outcome of BA of native COA. These data may im-
prove selection of candidates for BA
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1721-51 Transcatheter Management of Pulmonary
Atresia/Intact Ventricular Septum (PA/IVS) in 29
Neonates
Jean-Franyois Piechaud, Jean Kachaner, Angelica Delogu, Laurence Iserin,
Yacine Aggoun, Daniel Sidi. Hopital Necker/Enfants-malades, Paris, France
Twenty-nine infants aged 1-14 days had a 'favorable' form of PA/IVS includ-
ing a well developed outflow tract separated from the pulmonary artery by
an imperforated membrane, a tricuspid annulus>7 mms in diameter and no
coronary fistulae. All had deep cyanosis and suprasystemic right ventricular
(RVI systolic pressure. They received intravenous prostaglandin (PGE1) and
undervvent transcatheter perforation of the membrane with a guide-wire, or
more recently (6 cases) with a radio-frequency probe, followed by balloon
dilation. In 6 cases (21 %), we failed to perforate or to dilate. In the other
23 (79%), the RV pressure fell dramatically with an outflow gradient <30
mmHg. Sixteen (70%) recovered an adequate antegrade RV flow while on
PGEl within 1-21 days (m = 8.7 ± 7.4). They are still doing well but 3 of them
had a residual infundibular stenosis which did not respond to redilation and
had to be operated on. Seven (30%1 did not improve despite awidely open RV
outflow tract and PGEl had to be replaced by a surgical shunt, with 2 deaths
and 510ng term recoveries. Non fatal complications included ductal injury (2).
myocardial perforation (1). necrotizing enterocolitis 12), sepsis (1).
In conclusion, owing to technical advances such as the use of radio-
frequency currents, relief of the outflow obstruction can be obtained in 80%
of the neonates with favorable forms of PAlIVS. As soon as the RV has recov-
ered its diastolicfunction, an adequateforvvard flow will appear. PGEl should
be infused in the meantime and surgery will be avoided in 61 % of the cases.
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PUlmonary Balloon Valvuloplasty: Effective Palliation
for Infants with Tetralogy of Fallot and Small
Pulmonary Arteries
Julie A Vincent, Ronald G. Grifka, Michael R. Nihill, Charles E. Mullins, Frank F. lng,
Cameron J. Ward. Texas Children's Hospital, Houston, Texas
Infants with tetralogy of Fallot (TOF) and small pulmonary arteries IPAs) may
need palliation to improve pulmonary blood flow and allow growth of the PAs
prior to complete repair. Shunts may become occluded, distort the PAs or
cause pulmonary overcirculation. As an alternative palliation, we performed
pulmonary balloon valvuloplasty (PBV) on infants with TOF and small PAs.
20 infants, ages 1.8 ± 1.5 mo and weights 4.1 ± 1.6 kg, undervvent PBV
as initial palliation for persistent cyanosis or "spells". 4120 pts were intubated
prior to or for PBV All pts had pre and post-PBV angiograms. In all pts, single
balloon valvuloplasty was performed. The ratio of balloon: pulmonary valve
annulus (PVA) diameter was 1.51 ± 0.32. Post-PBV, there was no change in
the PYA diameter (5.2 ± 1.1 mm vs 5.6 + 1.1 mm; p = 0.1) or PA branch di-
ameter(4.1 ± 1.6 mm vs 4.5 ± 1.7 mm, p > 0.05). The systemic 02 saturation
increased from 81 ± 8% to 93 ± 6%. (p < 0.001).
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7/20 pts undervvent follow-up (F/U) cath 8.2 ± 2.4 mo post-PBV Compared
to pre-PBV measurements, the PYA diameter increased from 5.2 ± 1.1 mm
to 7.1 ± 1.4 mm (p < 0.03) and the McGoon ratio increased from 1.4 ± 0.4 to
2.1 ± 0.3 (p < 0.02).
Of the 20 pts, 11 pts undervvent corrective surgery 8.0 ± 3.1 mo post-PBV
with no surgical deaths; 5 pts remain in stable condition awaiting surgery;
3 pts required shunt placement 9-66 days post-PBV; 1 pt died due to other
congenital anomalies.
Conclusions: Pulmonary balloon valvuloplasty promotes growth of the PAs
and PYA in infants with TOF and small PAs, offering a safe and effective alter-
native palliation for infants who are not yet candidates for complete repair.
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1722-1 I High Dose Dobutamine Echocardlography Detects
Myocardial Viability and Ischemia in Coronary
Cardiomyopathy
Stephen J. Lewis, Stephen G. Sawada, Samer Khouri. Mark O'Shaughnessy,
Judy Foltz. John R. Bates, Douglas S. Segar, Thomas Ryan, Gary D. Hutchins,
Harvey Feigenbaum. Indiana University School of Medicine, Indianapolis. IN
Augmentation of wall motion during low dose (~1 0 meg/kg/min) dobutamine
infusion has been utilized to detect myocardial viability in patients with is-
chemic cardiomyopathy. The utility of high dose (30-50 mcglkg/min) dobu-
tamine infusion to detect viable and compromised myocardium has not been
described. Thirty-three patients with ischemic cardiomyopathy (mean EF of
0.33 ± 0.084) had low and high dose dobutamine echocardiograms and
positron emission tomography (PET) using N-13 ammonia (NH3) and fluo-
rodeoxyglucose (FOG). Left ventricular wall motion, NH3 and FOG uptake
were scored using a 16 segment model. Of 490 interpretable segments, 321
(66%)were abnormal at rest. At low dose 85 (27%) segments augmented of
which 80 (94%) were viable by PET. In 15 patients. an additional 32 (10%)
abnormal segments augmented at high dose. PET viability was noted in
29 (91 %) of these segments. In 18 of 33 patients (55%), 38 segments had
stress induced wall motion abnormalities at high dose. Of the 38 segments,
37 197%) were viable by PET. Angiography showed 34 of these 38 (89%)
segments were supplied by an obstructed coronary artery (:';:50% diameter
stenosis). Conclusions: 1) The use of higher doses increases the sensitivity of
DE to detect viable myocardium. 2) Deterioration of wall motion at peak indi-
cates viable but compromised myocardium supplied by an obstructed coro-
nary artery.
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1722-21 Predicting Viability and Functional Recovery with
Dobutamine Echocardiography and Positron
Emission Tomography
Stephen J. Lewis, Stephen G. Sawada, John R. Bates, Judy Foltz. Douglas
S. Segar. Thomas Ryan. Gary D. Hutchins, Harvey Feigenbaum. Indiana University,
Indianapolis, iN
Positron emission tomography (PET) is considered the gold standard for de-
tecting myocardial viability. Unfortunately, PET is limited by availability and
cost. Dobutamine echocardiography (DE) may be a cost effective and more
available method of detecting viability. This report compared DE with PET in
33 patients (ptsl with advanced coronary disease using a 16 segment model
for left ventricular wall motion and uptake of fluorodeoxyglucose (FOG). PET
viability was defined as normal or mildly reduced uptake of FOG. DE viability
was defined as preserved wall motion at rest or augmentation during DE. PET
showed evidence of viability in 93% (157/169) of segments with normal rest
wall motion, 85% (62/731 of mildly hypokinetic segments and 93% (68/73) of
severely hypokinetic segments. DE and PET were concordant in only 41 %
(71/175) of akinetic segments (46 nonviable and 25 viable). To investigate
this discordance we evaluated follow up echocardiograms (:,;:four weeks)
after coronary bypass surgery in 8 pts with 36 akinetic segments at rest.
The ability of PET and DE to predict functional recovery of wall motion is as
shown:
(+)PV HPV Sens Spec
PET 044 0.85 0.85 044
DE 0.60 0.73 046 083
PV = predictive value
